Professor Gregory G. Schwartz, MD, PhD

Professor of Medicine, University of Colorado School of Medicine
Chief, Cardiology Section, Rocky Mountain Regional VA Medical Center
Aurora, Colorado

Gregory G. Schwartz, MD, PhD, is Professor of Medicine (Division of Cardiology) at the University of Colorado and Chief of Cardiology at the Rocky Mountain Regional VA Medical Center in Aurora, Colorado (USA).

Dr Schwartz graduated from Brown University in Providence, RI with a degree in Biomedical Engineering, completed PhD and MD degrees from Duke University, residency and Chief Residency in Internal Medicine at the University of Colorado and fellowship in Cardiology at the University of California San Francisco (UCSF). He served as Assistant and Associate Professor at UCSF before assuming his present position.

Dr Schwartz’ has had continuous NIH and/or VA research funding for over 35 years. His basic research has focused on myocardial energetics in ischemia. His clinical research has focused on trials of lipid and metabolic interventions in coronary heart disease. These include the placebo-controlled cardiovascular outcomes trials that established the efficacy of intensive statin treatment (MIRACL, 2001) and PCSK9 inhibition (ODYSSEY OUTCOMES, 2018) after acute coronary syndrome. These trials have contributed to our understanding of lipoprotein(a) as a cardiovascular risk factor and potential target of treatment. Dr Schwartz currently chairs the US Department of Veterans Affairs VA-IMPACT trial, evaluating the cardiovascular efficacy of metformin versus placebo in 7400 patients with pre-diabetes.